The first results from an international experimental US antiviral drug are promising, even as a trial of the same drug in China shuts down.
More than half of a group of severely ill coronavirus patients from the US, Canada, Europe and Japan improved after taking remdesivir made by California-based Gilead Sciences.
Originally developed as a treatment for Ebola, the medication has been shown to fight against coronaviruses such as severe acute respiratory syndrome (SARS), which is a cousin of the new virus.
At the same time, a trial in China testing the drug in those with mild symptoms of the virus was suspended due to a lack of eligible patients.
However, some analysts believe that the trial was suspended because the drug was not proved to be effective
The first results of a trial testing remdesivir, a US-made Ebola drug, on severely ill coronavirus patients, was released. Pictured: A vial